SK bioscience is a South Korean pharmaceutical company specializing in the development and manufacturing of vaccines. It was spun-off from SK Chemicals in 2018 and is part of the SK Group, one of the largest enterprises in Korea. The company is committed to promoting human health through innovative vaccine solutions and has successfully developed South Korea's first COVID-19 vaccine.
Focus Areas
Notable Investments
